The pharmaceutical industry is one of the most regulated sectors globally. Companies looking to export medicines and other pharmaceutical products often face strict compliance requirements. One such critical requirement is the Certificate of Pharmaceutical Product (CoPP). This certificate plays a vital role in facilitating international trade, ensuring that exported drugs meet quality standards, and complying with regulatory requirements of importing countries.
A CoPP, also known as a Certificate of Pharmaceutical Product, is an official document issued by a country’s national regulatory authority. It confirms that a pharmaceutical product is authorized for sale in the country of origin and is manufactured according to Good Manufacturing Practices (GMP). The certificate typically contains details about the product, manufacturing site, marketing authorization, and compliance with national and international standards.The CoPP is widely used by importing countries to assess whether a pharmaceutical product is safe, effective, and compliant with international norms. It is particularly important when exporting to regulated markets where drug safety and quality are a primary concern.
Pharmaceutical companies and manufacturers that plan to export finished dosage forms, vaccines, or biologics to foreign countries are required to obtain a CoPP. Many importing nations, including those following WHO guidelines, make this certificate mandatory before allowing a product into their market.
The pharmaceutical product must be approved for marketing and sale in India. This includes having valid drug licenses and approvals from the Central Drugs Standard Control Organization (CDSCO).
The manufacturing site must comply with WHO-GMP standards. This ensures that products meet international quality and safety norms.
Documents typically include product licenses, manufacturing license, GMP certificate, marketing authorization, product labels, and export declaration.
Applications for a CoPP are submitted to CDSCO or the relevant State Drug Authority, depending on the product type and export destination.
Regulatory authorities review documents, verify GMP compliance, and may conduct inspections. Once satisfied, the CoPP is issued, allowing the manufacturer to export the product legally.
At Corpzo, we provide end-to-end support for obtaining CoPP certificates. From document preparation and regulatory guidance to application submission and follow-up, our team ensures a smooth, efficient, and compliant process for pharmaceutical exporters.🌐 Website:www.corpzo.com
📞 Contact: +91 9999 139 391
The Central Drugs Standard Control Organization (CDSCO) or the respective State Drug Authority issues the CoPP.
It is mandatory in most regulated markets and highly recommended for global exports.
Typically, 2–4 weeks, depending on document verification and inspections.
Yes, GMP compliance is a key requirement for issuing the CoPP.
Corpzo handles documentation, regulatory coordination, application filing, and ensures timely issuance of CoPP for exporters.